UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

A Combination of Complement Activation Products With Autoantibodies Predicts Transition of Probable Lupus to Systemic Lupus Erythematosus: Comment on the Article by Lambers et al

Arthritis care & research (2010), 2020-12, Vol.72 (12), p.1827-1827

2020

Volltextzugriff (PDF)

Role of Platelet-Bound C4d (PC4d) in Predicting Risk of Future Thrombotic Events in Systemic Lupus Erythematosus

Arthritis care & research (2010), 2023-10, Vol.75 (10), p.2088-2095

2023

Volltextzugriff (PDF)

Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology–Classified Systemic Lupus Erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2020-01, Vol.72 (1), p.78-88

2020

Volltextzugriff (PDF)

Antiphospholipid antibodies are persistently positive at high titers. Additive value of platelet-bound C4d

Frontiers in immunology, 2022-08, Vol.13, p.949919-949919

2022

Volltextzugriff (PDF)

Cell-bound complement activation products in SLE

Lupus science & medicine, 2017-01, Vol.4 (1), p.e000236-e000236

2017

Volltextzugriff (PDF)

A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosus

Lupus science & medicine, 2021-07, Vol.8 (1), p.e000528

2021

Volltextzugriff (PDF)

501 Role of platelet-bound complement activation product (PC4d) in predicting risk of future thrombotic events in systemic lupus erythematosus

Lupus science & medicine, 2022-12, Vol.9 (Suppl 3), p.A17-A18

2022

Volltextzugriff (PDF)

Transition of Methotrexate Polyglutamate Drug Monitoring Assay from Venipuncture to Capillary Blood-Based Collection Method in Rheumatic Diseases

The journal of applied laboratory medicine, 2019-07, Vol.4 (1), p.40-49

2019

Volltextzugriff (PDF)

303 Clinical and laboratory associations of longitudinal cell-bound complement activation products in SLE

Lupus science & medicine, 2024-05, Vol.11 (Suppl 2), p.A19-A20

2024

Volltextzugriff (PDF)

Erythrocyte complement receptor 1 (ECR1) and erythrocyte-bound C4d (EC4d) in the prediction of poor pregnancy outcomes in systemic lupus erythematosus (SLE)

Lupus science & medicine, 2022-09, Vol.9 (1), p.e000754

2022

Volltextzugriff (PDF)

616 Lower hydroxychloroquine blood levels are associated with higher Type 1 and 2 lupus activities

Lupus science & medicine, 2022-12, Vol.9 (Suppl 3), p.A39-A41

2022

Volltextzugriff (PDF)

The Avise Lupus Test and Cell-bound Complement Activation Products Aid the Diagnosis of Systemic Lupus Erythematosus

The open rheumatology journal, 2016-10, Vol.10 (1), p.71-80

2016

Volltextzugriff (PDF)

Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLE

Lupus science & medicine, 2019-01, Vol.6 (1), p.e000349-e000349

2019

Volltextzugriff (PDF)

1109 Clinical and laboratory manifestations of SLE patients with elevated cell-bound complement activation products

Lupus science & medicine, 2021-11, Vol.8 (Suppl 2), p.A36-A36

2021

Volltextzugriff (PDF)

A Multianalyte Assay Panel With Cell‐Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology–Classified Lupus

ACR open rheumatology, 2021-02, Vol.3 (2), p.116-123

2021

Volltextzugriff (PDF)

Cell-bound complement activation products associate with lupus severity in SLE

Lupus science & medicine, 2020-05, Vol.7 (1), p.e000377

2020

Volltextzugriff (PDF)

COX-2–Dependent Cardiac Failure in Gh/tTG Transgenic Mice

Circulation research, 2003-05, Vol.92 (10), p.1153-1161

2003

Volltextzugriff (PDF)

Capillary blood collected on volumetric absorptive microsampling (VAMS) device for monitoring hydroxychloroquine in rheumatoid arthritis patients

Journal of pharmaceutical and biomedical analysis, 2017-06, Vol.140, p.334-341

2017

Volltextzugriff (PDF)

Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies

Journal of autoimmunity, 2024-09, Vol.148, p.103299, Article 103299

2024

Volltextzugriff (PDF)

Validation of a multi-analyte panel with cell-bound complement activation products for systemic lupus erythematosus

Journal of immunological methods, 2017-07, Vol.446, p.54-59

2017

Volltextzugriff (PDF)

Capillary Blood Levels of Hydroxychloroquine and Methotrexate Are Stable for up to 5 Years When Collected on Volumetric Absorptive Microsamplers

The journal of applied laboratory medicine, 2021-07, Vol.6 (4), p.858-867

2021

Volltextzugriff (PDF)

Cell bound complement activation products alone and in combination with low serum complement C3 or C4 have superior diagnostic performance in systemic lupus erythematosus

The Journal of immunology (1950), 2019-05, Vol.202 (1_Supplement), p.182-182.8

2019

Volltextzugriff (PDF)

Differential Signaling by the Thromboxane Receptor Isoforms via the Novel GTP-binding Protein, Gh

The Journal of biological chemistry, 1999-04, Vol.274 (18), p.12774-12779

1999

Volltextzugriff (PDF)

Rapid, Agonist-dependent Phosphorylation in Vivo of Human Thromboxane Receptor Isoforms

The Journal of biological chemistry, 1997-03, Vol.272 (11), p.7191-7200

1997

Volltextzugriff (PDF)

Regulation of Cyclooxygenases by Protein Kinase C

The Journal of biological chemistry, 1996-11, Vol.271 (47), p.30028-30033

1996

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(43)

Sprache

Englisch
(43)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Humans
(18)
Lupus
(11)
Biomarkers
(10)
Rheumatology
(9)
Female
(8)
Male
(7)
Biological And Medical Sciences
(6)
Adult
(5)
Animals
(5)
Complement Activation
(5)
Systemic Lupus Erythematosus
(5)
Arthritis
(4)
Biochemistry & Molecular Biology
(4)
Flow Cytometry
(4)
Immunology
(4)
Lupus Erythematosus, Systemic - Diagnosis
(4)
Middle Aged
(4)
Proteins
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A Combination of Complement Activation Products With Autoantibodies Predicts Transition of Probable Lupus to Systemic Lupus Erythematosus: Comment on the Article by Lambers et al

Role of Platelet-Bound C4d (PC4d) in Predicting Risk of Future Thrombotic Events in Systemic Lupus Erythematosus

Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology–Classified Systemic Lupus Erythematosus

Antiphospholipid antibodies are persistently positive at high titers. Additive value of platelet-bound C4d

Cell-bound complement activation products in SLE

A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosus

501 Role of platelet-bound complement activation product (PC4d) in predicting risk of future thrombotic events in systemic lupus erythematosus

Transition of Methotrexate Polyglutamate Drug Monitoring Assay from Venipuncture to Capillary Blood-Based Collection Method in Rheumatic Diseases

303 Clinical and laboratory associations of longitudinal cell-bound complement activation products in SLE

Erythrocyte complement receptor 1 (ECR1) and erythrocyte-bound C4d (EC4d) in the prediction of poor pregnancy outcomes in systemic lupus erythematosus (SLE)

616 Lower hydroxychloroquine blood levels are associated with higher Type 1 and 2 lupus activities

The Avise Lupus Test and Cell-bound Complement Activation Products Aid the Diagnosis of Systemic Lupus Erythematosus

Randomised prospective trial to assess the clinical utility of multianalyte assay panel with complement activation products for the diagnosis of SLE

1109 Clinical and laboratory manifestations of SLE patients with elevated cell-bound complement activation products

A Multianalyte Assay Panel With Cell‐Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology–Classified Lupus

Cell-bound complement activation products associate with lupus severity in SLE

COX-2–Dependent Cardiac Failure in Gh/tTG Transgenic Mice

Capillary blood collected on volumetric absorptive microsampling (VAMS) device for monitoring hydroxychloroquine in rheumatoid arthritis patients

Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies

Validation of a multi-analyte panel with cell-bound complement activation products for systemic lupus erythematosus

Capillary Blood Levels of Hydroxychloroquine and Methotrexate Are Stable for up to 5 Years When Collected on Volumetric Absorptive Microsamplers

Cell bound complement activation products alone and in combination with low serum complement C3 or C4 have superior diagnostic performance in systemic lupus erythematosus

Differential Signaling by the Thromboxane Receptor Isoforms via the Novel GTP-binding Protein, Gh

Rapid, Agonist-dependent Phosphorylation in Vivo of Human Thromboxane Receptor Isoforms

Regulation of Cyclooxygenases by Protein Kinase C

Suchergebnisse filtern